FAMILIAL TRANSITIO NAL CELL CARCINOM A

Purpose: Bladder cancer is a common malignancy, and a frequent cause of urological consul­ tation and surgical intervention. Except for smoking and certain occupational exposures, the etiology of bladder cancer is largely unknown* Although the majority of patients with bladder cancer do not have a family history of transitional cell carcinoma of the urinary tract, the study of familial transitional cell carcinoma may lead to knowledge of the pathogenesis of this disease. Materials and Methods: To evaluate the current understanding of familial transitional cell carcinoma, we reviewed the contemporary literature for case reports and epidemiological studies about this disease. Results: Numerous case reports document the clustering of transitional cell carcinoma in families, several of which demonstrate an extremely early age at onset of disease, which argues in favor of a genetic component to familial transitional cell carcinoma. The results of large epidemiological studies also suggest the existence of familial transitional cell carcinoma, and first degree relatives appear to have an increased risk for disease by a factor of 2. Familial clustering of smoking does not appear to be the cause of this increased risk. Conclusions: Familial transitional cell carcinoma may be the result of a genetically transm itted predisposition to disease, at least in some affected families. Further studies are required to identify candidate genes that may be responsible for this form of bladder cancer.

[1]  P. Walsh,et al.  Germline translocation t(5;20)(p15;q11) and familial transitional cell carcinoma. , 1996, The Journal of urology.

[2]  W. M. Linehan,et al.  Associations between Bladder Cancer Risk Factors and Tumor Stage and Grade at Diagnosis , 1994, Epidemiology.

[3]  H. Vasen What is hereditary nonpolyposis colorectal cancer (HNPCC). , 1994, Anticancer research.

[4]  L. Kiemeney,et al.  Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989. , 1994, European journal of cancer.

[5]  Familial transitional cell carcinoma and the Lynch syndrome II. , 1993, British journal of urology.

[6]  H. Lynch,et al.  Extracolonic cancer in hereditary nonpolyposis colorectal cancer , 1993 .

[7]  N. Day,et al.  Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis , 1993, International journal of cancer.

[8]  J. Chang-Claude,et al.  Life style and occupational risk factors for bladder cancer in Germany. A case‐control study , 1992, Cancer.

[9]  V. Stefanović,et al.  Urinary tract tumors and Balkan nephropathy in the South Morava River basin. , 1991, Kidney international. Supplement.

[10]  W. Burnett,et al.  Familial aggregation of bladder cancer stratified by smoking status. , 1991, Epidemiology.

[11]  M Castegnaro,et al.  Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary tract tumours in Bulgaria. , 1988, IARC scientific publications.

[12]  Ji-gang Chen,et al.  Studies on the relation between bladder cancer and benzidine or its derived dyes in Shanghai. , 1990, British journal of industrial medicine.

[13]  Kazunari Sato,et al.  A Pedigree of Cancer Family Syndrome with an Aggregation of Transitional Cell Cancer of the Urinary Tract , 1990 .

[14]  Z. Kırkalı,et al.  Epidemiological case-control study on the etiology of bladder cancer in Turkey. , 1990, European urology.

[15]  H. Lynch,et al.  The Lynch syndrome II and urological malignancies. , 1990, The Journal of urology.

[16]  H. Tómasson,et al.  The copenhagen case‐control study of renal pelvis and ureter cancer: Role of analgesics , 1989, International journal of cancer.

[17]  A. Miller,et al.  Risk of bladder cancer by source and type of tobacco exposure: A case‐control study , 1989, International journal of cancer.

[18]  G. Draper,et al.  Non-ocular cancer in relatives of retinoblastoma patients. , 1989, British Journal of Cancer.

[19]  B. Henderson,et al.  Analgesics, cigarette smoking, and other risk factors for cancer of the renal pelvis and ureter. , 1989, Cancer research.

[20]  C. la Vecchia,et al.  Dietary factors in the risk of bladder cancer. , 1989, Nutrition and cancer.

[21]  A. Miller,et al.  Dietary factors and the incidence of cancer of the urinary bladder. , 1988, American journal of epidemiology.

[22]  M. Bender,et al.  Normal G2 chromosomal radiosensitivity and cell survival in the cancer family syndrome. , 1988, Cancer research.

[23]  N. Nagelkerke,et al.  Non‐ocular cancer in patients with hereditary retinoblastoma and their relatives , 1988, International journal of cancer.

[24]  D. Grignon,et al.  Transitional cell carcinoma in the Muir-Torre syndrome. , 1987, The Journal of urology.

[25]  W. Kimberling,et al.  Familial bladder cancer in an oncology clinic. , 1987, Cancer genetics and cytogenetics.

[26]  M. P. Bravo,et al.  Risk factors of bladder cancer in Spain. , 1987, Neoplasma.

[27]  G. Matanoski,et al.  Bladder cancer in young women. , 1986, American journal of epidemiology.

[28]  H. Tesluk,et al.  Familial transitional cell carcinoma of renal pelvis and upper ureter. , 1986, Urology.

[29]  W. Waltzer,et al.  Bilateral transitional cell carcinoma of the renal pelvis in the cancer family syndrome. , 1985, The Journal of urology.

[30]  H. Lynch,et al.  Muir‐Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome , 1985, The British journal of dermatology.

[31]  P. Hartge,et al.  Familial and environmental interactions in bladder cancer risk , 1985, International journal of cancer.

[32]  M H Skolnick,et al.  Genetic epidemiology of cancer in utah genealogies: A prelude to the molecular genetics of common cancers , 1984, Journal of cellular physiology. Supplement.

[33]  K. Karjalainen,et al.  Excess of cancer deaths in close relatives of patients with bilateral retinoblastoma. , 1984, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[34]  D. Henson,et al.  Familial carcinoma of ureters and other genitourinary organs. , 1983, The Journal of urology.

[35]  J. Fraumeni,et al.  Etiology of cancer of the renal pelvis. , 1983, Journal of the National Cancer Institute.

[36]  J. Stewart,et al.  Analgesics and tobacco as risk factors for cancer of the ureter and renal pelvis. , 1983, The Journal of urology.

[37]  S. Mommsen,et al.  A case-control study of female bladder cancer. , 1983, European journal of cancer & clinical oncology.

[38]  S. Mommsen,et al.  An epidemiological case-control study of bladder cancer in males from a predominantly rural district. , 1982, European journal of cancer & clinical oncology.

[39]  D. Louria,et al.  Life time occupation, smoking, caffeine, saccharine, hair dyes and bladder carcinogenesis. , 1982, International journal of epidemiology.

[40]  J. W. Sullivan,et al.  Epidemiologic survey of bladder cancer in greater New Orleans. , 1982, The Journal of urology.

[41]  E. Mahboubi,et al.  Familial aggregation of urothelial carcinoma. , 1981, The Journal of urology.

[42]  H. Lynch,et al.  Familial factors in bladder carcinoma. , 1979, The Journal of urology.

[43]  R. Cartwright Genetic association with bladder cancer. , 1979, British medical journal.

[44]  D. Purtilo,et al.  Familial urinary bladder cancer. , 1979, Seminars in oncology.

[45]  T. Petkova-Bocharova,et al.  Familial aggregation of urinary system tumors in a region with endemic nephropathy. , 1978, Cancer research.

[46]  ChristopherJ. Williams MANAGEMENT OF MALIGNANCY IN "CANCER FAMILIES" , 1978, The Lancet.

[47]  C. T. Miller,et al.  Relative importance of risk factors in bladder carcinogenesis. , 1978, Journal of chronic diseases.

[48]  T. Petkova-Bocharova,et al.  Families with multiple cases of urinary system tumors: brief communication. , 1977, Journal of the National Cancer Institute.

[49]  C. Pratt,et al.  A new familial cancer syndrome? A spectrum of malignant and benign tumors including retinoblastoma, carcinoma of the bladder and other genitourinary tumors, thyroid adenoma, and a probable case of multifocal osteosarcoma. , 1977, Journal of the National Cancer Institute.

[50]  A. Morrison,et al.  Epidemiology of bladder cancer. , 1992, Hematology/oncology clinics of North America.

[51]  D. Lamm,et al.  Familial transitional cell carcinoma of the bladder. , 1975, The Journal of urology.

[52]  B. Henderson,et al.  Environmental exposure and bladder cancer in young males. , 1973, Journal of the National Cancer Institute.

[53]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[54]  J. Fraumeni,et al.  Malignant Bladder Tumors in a Man and His Three Sons , 1967 .

[55]  C. E. Burkland,et al.  Familial occurrence of carcinoma of the ureter. , 1966, The Journal of urology.

[56]  B. Harvald,et al.  HEREDITY OF CANCER ELUCIDATED BY A STUDY OF UNSELECTED TWINS. , 1963, JAMA.

[57]  Nathan Mantel,et al.  An epidemiological investigation of cancer of the bladder , 1963, Cancer.

[58]  G. Morganti,et al.  RECHERCHES CLINICO-STATISTIQUES ET GNTIQUES SUR LES NOPLASIES DE LA PROSTATE , 1956 .